Showing results (1241-1250 of 1,256) with videos related to

Sort By:
Pageof 126
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2024
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in OncologyEdward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
International Journal of Radiation Oncology, Biology, Physics|March 25, 2022
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic FactorsPaul W Sperduto, Brian De, Jing Li, et al.
Plos Pathogens|August 11, 2021
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19Cheng-Pu Sun, Jia-Tsrong Jan, I-Hsuan Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2010
Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distributionJeffrey A Pfefferkorn, John Litchfield, Richard Hutchings, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026Daniel E Spratt, Sandy Srinivas, Nabil Adra, et al.
EMBO Molecular Medicine|March 22, 2025
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesityYi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, et al.
The New England Journal of Medicine|May 16, 2019
Genomic Mismatch at <i>LIMS1</i> Locus and Kidney Allograft RejectionNicholas J Steers, Yifu Li, Zahida Drace, et al.
Journal of Biomedical Science|July 7, 2022
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variantsI-Jung Lee, Cheng-Pu Sun, Ping-Yi Wu, et al.
Pageof 126